Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: mc who wrote (4962)	7/17/1998 6:20:00 PM
From: Jacques Chitte	Read Replies (2) \| Respond to of 7041

Open Q to longs&shorts alike. Let's say Vasomax gets FDA approval. Let's further say it gains some patient acceptance. Is there anything preventing one of the generic drug houses from making phentolamine tabs? I've noticed that a few months ago a lot of hay was made over the Vasomax pill's unique composition. Now the tone is as if Vasomax and phentolamine are effectively the same. The generic drug house doesn't need to give an indication for their phentolamine preparation. I figure savvy doctors would write the prescription in an "open" manner allowing the generic. Thoughts?